175 related articles for article (PubMed ID: 34696204)
1. Adverse Events Following Immunization Associated with the First and Second Doses of the ChAdOx1 nCoV-19 Vaccine among Healthcare Workers in Korea.
Jeon M; Kim J; Oh CE; Lee JY
Vaccines (Basel); 2021 Sep; 9(10):. PubMed ID: 34696204
[TBL] [Abstract][Full Text] [Related]
2. Adverse Events Following Immunization Associated with Coronavirus Disease 2019 Vaccination Reported in the Mobile Vaccine Adverse Events Reporting System.
Jeon M; Kim J; Oh CE; Lee JY
J Korean Med Sci; 2021 May; 36(17):e114. PubMed ID: 33942578
[TBL] [Abstract][Full Text] [Related]
3. Incidence, Pattern and Severity of Adverse Events Following Immunization (AEFIs) Associated With Chadox1 nCOV-19 Corona Virus Vaccine (Recombinant) Among the Healthcare Workers of a Tertiary Care Institute of Eastern Uttar Pradesh, India.
Kamble B; Bashar MA; Mishra CP
Cureus; 2022 Feb; 14(2):e21848. PubMed ID: 35273834
[TBL] [Abstract][Full Text] [Related]
4. Reporting adverse events of ChAdOx1 nCoV-19 coronavirus vaccine (Recombinant) among the vaccinated healthcare professionals: A cross-sectional survey.
Kaur S; Singh A; Saini S; Rohilla L; Kaur J; Chandi A; Kaur G; Singh M; Kumar P; Soni SL; Kajal K; Naik NB; Malhotra P; Verma S; Gupta M; Devnani M; Das K; Pandav SS; Puri GD
Indian J Med Res; 2022 Jan; 155(1):123-128. PubMed ID: 35859438
[TBL] [Abstract][Full Text] [Related]
5. Active Safety Surveillance of Four Types of COVID-19 Vaccines: A National Study from Jordan.
Abdel-Qader DH; Abdel-Qader H; Silverthorne J; Kongkaew C; Al Meslamani AZ; Hayajneh W; Ata OMA; Shnaigat W; AbuRuz S; Al Nsour M; Alhariri A; Shnewer K; Da'ssan M; Obeidat NM; Nusair KE; Jalamdeh MS; Hawari F; Khader K; Hakim T; Hammad FA; Al Qudah M; Asad M
Clin Drug Investig; 2022 Oct; 42(10):813-827. PubMed ID: 35999428
[TBL] [Abstract][Full Text] [Related]
6. Adverse events following immunization with ChAdOx1 nCoV-19 and BBIBP-CorV vaccine: A comparative study among healthcare professionals of Nepal.
Rayamajhi S; Rafi MA; Tripathi N; Dongol AS; Pandey M; Rayamajhi S; Bhandari S; Shrestha P; Hasan MT; Hossain MG
PLoS One; 2022; 17(8):e0272729. PubMed ID: 35947626
[TBL] [Abstract][Full Text] [Related]
7. Surveillance on Adverse Events Following COVISHIELD (ChAdOx1 nCoV-19) vaccination in Goa, India: An Observational Study.
Jose D; Dhupdale N; Cacodcar JA; Kamat U
Curr Drug Saf; 2023; 18(4):516-527. PubMed ID: 35927820
[TBL] [Abstract][Full Text] [Related]
8. Adverse Reactions Following the First Dose of ChAdOx1 nCoV-19 Vaccine and BNT162b2 Vaccine for Healthcare Workers in South Korea.
Bae S; Lee YW; Lim SY; Lee JH; Lim JS; Lee S; Park S; Kim SK; Lim YJ; Kim EO; Jung J; Kwon HS; Kim TB; Kim SH
J Korean Med Sci; 2021 May; 36(17):e115. PubMed ID: 33942579
[TBL] [Abstract][Full Text] [Related]
9. Active Symptom-Based Surveillance of Adverse Events Following Immunization Among Individuals Vaccinated with ChAdOx1 nCoV-19 Coronavirus Vaccine in a Tertiary Hospital of Kerala.
Jose M; Rajmohan P; Thomas J; Krishna S; Antony B; Gopinathan UU; Iyyapan EM; Porinchu RM; Jose P; Raphael L; Kuttichira P
Curr Drug Saf; 2022; 17(4):327-334. PubMed ID: 35135453
[TBL] [Abstract][Full Text] [Related]
10. Adverse Events in Healthcare Workers after the First Dose of ChAdOx1 nCoV-19 or BNT162b2 mRNA COVID-19 Vaccination: a Single Center Experience.
Kim SH; Wi YM; Yun SY; Ryu JS; Shin JM; Lee EH; Seo KH; Lee SH; Peck KR
J Korean Med Sci; 2021 Apr; 36(14):e107. PubMed ID: 33847085
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of mRNA-BNT162b2, mRNA-1273, and ChAdOx1 nCoV-19 vaccines against COVID-19 in healthcare workers: an observational study using surveillance data.
Paris C; Perrin S; Hamonic S; Bourget B; Roué C; Brassard O; Tadié E; Gicquel V; Bénézit F; Thibault V; Garlantézec R; Tattevin P
Clin Microbiol Infect; 2021 Nov; 27(11):1699.e5-1699.e8. PubMed ID: 34265462
[TBL] [Abstract][Full Text] [Related]
12. A prospective observational safety study on ChAdOx1 nCoV-19 corona virus vaccine (recombinant) use in healthcare workers- first results from India.
Kaur U; Ojha B; Pathak BK; Singh A; Giri KR; Singh A; Das A; Misra A; Yadav AK; Kansal S; Chakrabarti SS
EClinicalMedicine; 2021 Aug; 38():101038. PubMed ID: 34505032
[TBL] [Abstract][Full Text] [Related]
13. Description of Frequencies of Reported Adverse Events Following Immunization Among Four Different COVID-19 Vaccine Brands.
Kant A; Jansen J; van Balveren L; van Hunsel F
Drug Saf; 2022 Apr; 45(4):319-331. PubMed ID: 35314943
[TBL] [Abstract][Full Text] [Related]
14. Incidence of Early Adverse Events Following Covishield (ChAdOx1 nCoV-19) Vaccination: A Prospective Study.
Velhal GD; Kamath YV; Agrawal AS; Vora DS; Dwivedi VR
Indian J Community Med; 2022; 47(4):613-617. PubMed ID: 36742958
[TBL] [Abstract][Full Text] [Related]
15. Adverse events following introduction of the ChAdOx1 nCoV-19 vaccine in Somalia in 2021: findings from a fragile setting and implications for the future.
Hamayoun M; Abdulrazak I; Farid M; Malik MR; Mohamud MF
IJID Reg; 2022 Sep; 4():47-52. PubMed ID: 35720961
[TBL] [Abstract][Full Text] [Related]
16. [Adverse events following immunization reported with COVID-19 vaccines in Burkina Faso: Analysis of spontaneous reports].
Sawadogo R; Ouoba J; Ilboudo D; Tchoumbi E; Lankoandé-Haro S; Fofana S; Sombié I; Samadoulougou S; Kirakoya-Samadoulougou F
Sante Publique; 2024 Feb; 35(6):149-159. PubMed ID: 38388395
[TBL] [Abstract][Full Text] [Related]
17. ChAdOx1 nCoV-19 Vaccine Side Effects among Healthcare Workers in Trinidad and Tobago.
Gopaul CD; Ventour D; Thomas D
Vaccines (Basel); 2022 Mar; 10(3):. PubMed ID: 35335098
[TBL] [Abstract][Full Text] [Related]
18. Barriers to COVID-19 vaccine surveillance: the issue of under-reporting adverse events.
Noh Y; Ko HY; Kim JH; Yoon D; Choe YJ; Choe SA; Jung J; Shin JY
Epidemiol Health; 2023; 45():e2023054. PubMed ID: 37309115
[TBL] [Abstract][Full Text] [Related]
19. Serum Antibody Response Comparison and Adverse Reaction Analysis in Healthcare Workers Vaccinated with the BNT162b2 or ChAdOx1 COVID-19 Vaccine.
Lim SH; Choi SH; Kim B; Kim JY; Ji YS; Kim SH; Kim CK; Kim T; Choo EJ; Moon JE; Yun J; Park SK
Vaccines (Basel); 2021 Nov; 9(12):. PubMed ID: 34960125
[TBL] [Abstract][Full Text] [Related]
20. Incidence and clinical characteristics of adverse neurological events and stroke-like syndrome associated with immune stress-related response after COVID-19 vaccination in 2021 from Thailand.
Sirisuk W; Limvorapitak W; Lolekha P; Methaset K; Kulkantrakorn K
Clin Neurol Neurosurg; 2023 Aug; 231():107804. PubMed ID: 37295197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
